<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">

<channel>
	<title>TB R&amp;D Matters Blog</title>
	
	<link>http://www.newtbdrugs.org/blog</link>
	<description>Working Towards a Faster Cure for Tuberculosis</description>
	<lastBuildDate>Wed, 15 May 2013 17:30:21 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.feedburner.com/WorkingGroupOnNewTBDrugsBlog" /><feedburner:info uri="workinggrouponnewtbdrugsblog" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>WorkingGroupOnNewTBDrugsBlog</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><item>
		<title>UPDATE Exposed:  Aeras’ Upcoming Film Series on Tuberculosis</title>
		<link>http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/iZBBYZAhCFI/</link>
		<comments>http://www.newtbdrugs.org/blog/exposed-aeras-upcoming-film-series-on-tuberculosis/#comments</comments>
		<pubDate>Wed, 15 May 2013 14:59:45 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[aeras]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[vaccines]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4266</guid>
		<description><![CDATA[Release of Part 1 of EXPOSED scheduled for the week of May 20.   EXPOSED is a four-part series of short films that tell the story of the deadly global epidemic of tuberculosis. The series will portray the struggles of four inspiring individuals - an MDR-TB survivor, a TB doctor, a clinical trial volunteer, and a TB vaccine researcher - bringing viewers to the forefront of the race against tuberculosis.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/exposed-aeras-upcoming-film-series-on-tuberculosis/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.newtbdrugs.org/blog/exposed-aeras-upcoming-film-series-on-tuberculosis/</feedburner:origLink></item>
		<item>
		<title>Tagline Spring 2013:  3 Articles on TB Research</title>
		<link>http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/9NkRsrPOaNs/</link>
		<comments>http://www.newtbdrugs.org/blog/tagline-spring-2013-3-articles-on-tb-research/#comments</comments>
		<pubDate>Fri, 26 Apr 2013 20:01:00 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB Pediatrics]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[markets]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[TAG]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4290</guid>
		<description><![CDATA[Treatment Action Group (TAG) recently released its Spring 2013 issue of tagline, which contains three articles about TB research that might be of interest to you-- 1) on rifapentine research and access, 2) on adaptive clinical trial designs, and 3) on pediatric drug development needs. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tagline-spring-2013-3-articles-on-tb-research/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.newtbdrugs.org/blog/tagline-spring-2013-3-articles-on-tb-research/</feedburner:origLink></item>
		<item>
		<title>Medecins Sans Frontieres/Doctors Without Borders Scientific Day May 10th</title>
		<link>http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/fCojTXkgaxo/</link>
		<comments>http://www.newtbdrugs.org/blog/medecins-sans-frontieresdoctors-without-borders-scientific-day-may-10th/#comments</comments>
		<pubDate>Tue, 16 Apr 2013 22:17:28 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Patient Perspective]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[doctors without borders]]></category>
		<category><![CDATA[global health]]></category>
		<category><![CDATA[health conference]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[msf]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[scientific awards]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4284</guid>
		<description><![CDATA[MSF Scientific Day is a unique opportunity to showcase medical and scientific research carried out in MSF programmes around the world.  Presenting and debating the findings from our research is vital to improve the quality of our humanitarian programmes.  There will be several topic s on tuberculosis.
]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/medecins-sans-frontieresdoctors-without-borders-scientific-day-may-10th/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.newtbdrugs.org/blog/medecins-sans-frontieresdoctors-without-borders-scientific-day-may-10th/</feedburner:origLink></item>
		<item>
		<title>New Database Tracks Health Technology Innovations</title>
		<link>http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/YZeSKI1zKZc/</link>
		<comments>http://www.newtbdrugs.org/blog/new-database-tracks-health-technology-innovations/#comments</comments>
		<pubDate>Tue, 16 Apr 2013 22:04:06 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[market access]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[center for health market innovations]]></category>
		<category><![CDATA[chmi]]></category>
		<category><![CDATA[database]]></category>
		<category><![CDATA[global health]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[online tool]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[stop tb]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4279</guid>
		<description><![CDATA[The Center for Health Market Innovations (CHMI) has compiled profiles on over 1,200 programs and counting.  For TB innovations, the CHMI database contains 58 programs that work on TB in 33 countries. 

]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/new-database-tracks-health-technology-innovations/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.newtbdrugs.org/blog/new-database-tracks-health-technology-innovations/</feedburner:origLink></item>
		<item>
		<title>TB Edition of The Lancet Infectious Diseases</title>
		<link>http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/-C47AhmFc9U/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-edition-of-the-lancet-infectious-diseases/#comments</comments>
		<pubDate>Wed, 27 Mar 2013 17:27:58 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[cptr]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[infectious diseases]]></category>
		<category><![CDATA[lancet]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[stop tb partnership]]></category>
		<category><![CDATA[tb alliance]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4272</guid>
		<description><![CDATA[To commemorate World TB Day 2013, The Lancet Infectious Diseases publishes a Series of papers on tuberculosis, a disease that has long plagued human beings and was declared a global emergency in 1993 by WHO. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-edition-of-the-lancet-infectious-diseases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.newtbdrugs.org/blog/tb-edition-of-the-lancet-infectious-diseases/</feedburner:origLink></item>
		<item>
		<title>Get Ready for World TB Day March 24, 2013!</title>
		<link>http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/_m5dcE3KoZ4/</link>
		<comments>http://www.newtbdrugs.org/blog/get-ready-for-world-tb-day-march-24-2013/#comments</comments>
		<pubDate>Wed, 20 Mar 2013 21:19:29 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Events]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[march 24]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[stigma]]></category>
		<category><![CDATA[stop tb]]></category>
		<category><![CDATA[stop tb partnership]]></category>
		<category><![CDATA[tb alliance]]></category>
		<category><![CDATA[the union]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[wgnd]]></category>
		<category><![CDATA[WHO]]></category>
		<category><![CDATA[world tb day]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4256</guid>
		<description><![CDATA[World TB Day is celebrated on March 24 and there is a lot going on during this week and next to highlight the continued problem of TB in the world and the solutions to address the problem. Included is a list of publications, news items, events, and links related to TB and World TB Day 2013.  ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/get-ready-for-world-tb-day-march-24-2013/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.newtbdrugs.org/blog/get-ready-for-world-tb-day-march-24-2013/</feedburner:origLink></item>
		<item>
		<title>TB R&amp;D Weekly Update:  TB Vaccine Efficacy Trial Yields Key Insights and Poor Results</title>
		<link>http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/7LzGNMAymcI/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tb-vaccine-efficacy-trial-yields-key-insights-and-poor-results/#comments</comments>
		<pubDate>Mon, 04 Feb 2013 21:10:42 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Pediatrics]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[aeras]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[mva85a]]></category>
		<category><![CDATA[oxford]]></category>
		<category><![CDATA[pediatric]]></category>
		<category><![CDATA[phase II]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[tbvi]]></category>
		<category><![CDATA[vaccines]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4243</guid>
		<description><![CDATA[The results of the first TB vaccine efficacy trial in over 90 years was released today showing that the vaccine candidate MVA85A when given as a booster did not provide added protection to infants who had already received BCG.  The trial adds scientific value to the field and enhances the field's understanding and ability in conducting large-scale TB vaccine trials.  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tb-vaccine-efficacy-trial-yields-key-insights-and-poor-results/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tb-vaccine-efficacy-trial-yields-key-insights-and-poor-results/</feedburner:origLink></item>
		<item>
		<title>Bedaquiline Receives Accelerated Approval from the FDA for MDR-TB Rx</title>
		<link>http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/PbSdzvF-6Xw/</link>
		<comments>http://www.newtbdrugs.org/blog/bedaquiline-receives-accelerated-approval-from-the-fda-for-mdr-tb-rx/#comments</comments>
		<pubDate>Mon, 07 Jan 2013 02:34:41 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[Regulations and Guidelines]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[fda]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[janssen]]></category>
		<category><![CDATA[johnson and johnson]]></category>
		<category><![CDATA[markets]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4235</guid>
		<description><![CDATA[The FDA granted Janssen's TB drug Bedaquiline accelerated approval for treatment of MDR-TB.  A link is provided to the FDA press release and Janssen's full press release is included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/bedaquiline-receives-accelerated-approval-from-the-fda-for-mdr-tb-rx/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.newtbdrugs.org/blog/bedaquiline-receives-accelerated-approval-from-the-fda-for-mdr-tb-rx/</feedburner:origLink></item>
		<item>
		<title>Multidrug-Resistance Tuberculosis: No Promises</title>
		<link>http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/FigJXjXT-ho/</link>
		<comments>http://www.newtbdrugs.org/blog/multidrug-resistance-tuberculosis-no-promises/#comments</comments>
		<pubDate>Thu, 13 Dec 2012 21:31:07 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Faces of TB]]></category>
		<category><![CDATA[Video]]></category>
		<category><![CDATA[Voices from the Fight to Stop Tuberculosis]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[msf]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[voices]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4218</guid>
		<description><![CDATA[A video from Medecins Sans Frontieres entitled "Multidrug-Resistance Tuberculosis: No Promises" on the situation of children affected with MDR-TB. It highlights the dire plight of children being treated for MDR-TB in Tajikistan.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/multidrug-resistance-tuberculosis-no-promises/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		<feedburner:origLink>http://www.newtbdrugs.org/blog/multidrug-resistance-tuberculosis-no-promises/</feedburner:origLink></item>
		<item>
		<title>FDA Advisory Committee recommends Janssen’s Bedaquiline for accelerated approval</title>
		<link>http://feedproxy.google.com/~r/WorkingGroupOnNewTBDrugsBlog/~3/D9pmcgu87Hs/</link>
		<comments>http://www.newtbdrugs.org/blog/fda-advisory-committee-recommends-janssens-bedaquiline-for-accelerated-approval/#comments</comments>
		<pubDate>Thu, 29 Nov 2012 18:16:40 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[market access]]></category>
		<category><![CDATA[Regulations and Guidelines]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[bedaquiline]]></category>
		<category><![CDATA[fda]]></category>
		<category><![CDATA[janssen]]></category>
		<category><![CDATA[johnson & johnson]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[TMC-207]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=4213</guid>
		<description><![CDATA[Yesterday, Nov. 28th, the FDA Ant-infective Drug Advisory Committee voted to recommend Janssen's Bedaquiline for accelerated approval for the treatment of MDR tuberculosis. A summary of the proceedings is included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/fda-advisory-committee-recommends-janssens-bedaquiline-for-accelerated-approval/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
		<feedburner:origLink>http://www.newtbdrugs.org/blog/fda-advisory-committee-recommends-janssens-bedaquiline-for-accelerated-approval/</feedburner:origLink></item>
	</channel>
</rss>
